Caire
CAIRE Inc. is a global oxygen therapy and respiratory care manufacturer, producing portable and stationary oxygen concentrators, liquid oxygen systems, cardiorespiratory diagnostic equipment (via MGC Diagnostics), and industrial PSA/VPSA gas generators (via AirSep) for medical, commercial, and military customers across 117+ countries.
- Company typePrivate
- Founded1970
- HeadquartersBall Ground, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Caire does
CAIRE Inc. is a global manufacturer of medical and commercial oxygen delivery systems, headquartered in Ball Ground, Georgia, and operating as a wholly-owned subsidiary of Japanese conglomerate Niterra Co., Ltd. (formerly NGK Spark Plug) since 2018. The company serves three end-markets: patient oxygen therapy (portable and stationary oxygen concentrators such as FreeStyle Comfort, Eclipse 5, Companion 5, and NewLife Intensity, plus liquid oxygen systems under the HELiOS brand), clinical cardiorespiratory diagnostics (via the January 2023 MGC Diagnostics acquisition, including the Fenom Flo portable FeNO monitor), and industrial/commercial on-site gas generation (PSA and VPSA oxygen plants and nitrogen generators via the AirSep division). Core technology is rooted in Pressure Swing Adsorption and Vacuum Pressure Swing Adsorption gas separation, complemented by proprietary oxygen-delivery firmware including autoSAT, UltraSense, and autoDOSE that modulate oxygen bolus delivery to patient breath rate.
The business operates a hybrid go-to-market: direct enterprise sales to hospitals, government buyers, and industrial customers in seven core geographies (USA, Japan, China, Germany, Italy, Australia), augmented by authorized distributors such as Sunset Healthcare Solutions (Canada) and Chemonics International (humanitarian deployments), plus an authorized service network (e.g., Careica Health). Revenue is generated primarily through hardware sales of oxygen concentrators, diagnostic systems, and industrial gas generation equipment, supplemented by aftermarket service, parts, and accessories. Pricing is quote-based and not publicly disclosed, with multi-year contracts typical for institutional and government accounts. Customer reach spans 117+ countries, with 5,000+ AirSep hospital installations across approximately 50 countries, and recurring product launches in 2025-2026 (Centrox-CR, FreeStyle Comfort with autoSAT, Fenom Flo) suggest continued product-line momentum under Niterra's ownership.
Caire firmographics
Firmographics- Name
- Caire
- Legal name
- CAIRE Inc.
- Website
- https://caireinc.com
- Company type
- Private
- Founded year
- 1970
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- CAIRE Inc. is a global oxygen therapy and respiratory care manufacturer, producing portable and stationary oxygen concentrators, liquid oxygen systems, cardiorespiratory diagnostic equipment (via MGC Diagnostics), and industrial PSA/VPSA gas generators (via AirSep) for medical, commercial, and military customers across 117+ countries.
- Ownership category
- akta.pro rank
Caire industry classification
Industry- Product category
- Medical Oxygen Therapy Equipment
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Automatic Environmental Control Manufacturing for Residential, Commercial, and Appliance Use (334512), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC) (HLAHAGAD)
- akta.pro secondary industries
- Ventilation, Ducting & Air Distribution Equipment (IMAHAKAG), Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD)
Keywords
Where Caire is headquartered
LocationHeadquarters
- HQ city
- Ball Ground
- HQ country
- United States
- HQ region
- North America
Offices8 records
Markets served
Caire business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Medical Oxygen Therapy Equipment Sales: CAIRE generates revenue through the sale of portable oxygen concentrators, stationary oxygen concentrators, and liquid oxygen systems for patients with respiratory conditions such as COPD. Products include FreeStyle Comfort, Eclipse 5, Companion 5, and NewLife Intensity.
- Commercial/Industrial Oxygen Generation Systems: Revenue from AirSep division selling oxygen and nitrogen generators for commercial and industrial applications including hospitals, wastewater treatment, aquaculture, gold leaching, and manufacturing.
- Cardiorespiratory Diagnostic Systems: Revenue from MGC Diagnostics products including non-invasive cardiorespiratory diagnostic systems for clinical settings to serve patients with cardiorespiratory diseases.
- Service and Support: CAIRE provides technical support, authorized service network, and parts/accessories for its product portfolio, maintaining customer relationships post-sale.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | No public pricing available |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels3 records
Caire product offering
Product offeringCore offering
CAIRE manufactures and sells oxygen therapy products (portable and stationary oxygen concentrators, liquid oxygen systems) and cardiorespiratory diagnostic systems for medical and commercial use. The company also provides on-site PSA/VPSA oxygen and nitrogen generation systems for hospitals, industrial facilities, and military applications, operating under brands including AirSep, HELiOS, SeQual, and MGC Diagnostics.
Product overview
CAIRE Inc. is a leading global dedicated oxygen supply manufacturer offering a comprehensive portfolio of medical and commercial products. The product architecture is organized around three core pillars: (1) Oxygen Therapy products for patients including the FreeStyle Comfort and Eclipse 5 portable oxygen concentrators, Companion 5 and NewLife Intensity 10 stationary concentrators, and liquid oxygen systems; (2) Cardiorespiratory Diagnostics through acquired MGC Diagnostics brand featuring the Fenom Flo portable FeNO monitor; and (3) Commercial/Industrial applications via the AirSep sub-brand including PSA and VPSA oxygen generators, nitrogen generators, and cylinder refilling systems like the Centrox-CR. The company also offers the myCAIRE telehealth add-on module for remote patient monitoring. CAIRE operates under parent company Niterra (formerly NGK SPARK PLUG CO., LTD.) and maintains global manufacturing operations with headquarters in Ball Ground, Georgia.
Differentiator
Problem solved
Functional benefit
Brands
- FreeStyle Comfort: Award-winning portable oxygen concentrator with proprietary autoSAT technology that auto-adjusts oxygen delivery to the patient's breath rate
- Eclipse 5
- Companion 5
- NewLife Intensity 10
- SAROS Oxygen System
- Fenom Flo
- Centrox-CR
- myCAIRE
- N2WAVE
- CAIREview
- UltraSense
- autoDOSE
- autoSAT
Products and services
- FreeStyle Comfort Portable oxygen concentrator with proprietary autoSAT technology that automatically adjusts oxygen delivery to match the patient's breath rate during activity or rest. Weighs 5 pounds and includes UltraSense and autoDOSE technologies for patient-friendly oxygen therapy.
- Eclipse 5
Quantifiable outcome
- More than 5,000 hospitals in nearly 50 countries rely on AirSep PSA Medical Oxygen Systems
- +2 more outcomes
Companies that use Caire
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Caire technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Caire partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- USAID (United States Agency for International Development)coreUSAID partnered with AirSep (CAIRE) to provide medical oxygen systems in developing countries. Projects include the first AirSep PSA Oxygen System in Mozambique at Monapo Hospital, capable of treating 25 COVID-19 patients with severe symptoms and 150 with milder needs. Partnership also includes Ghana installations through Chemonics International.
- Chemonics InternationalcoreChemonics International serves as an AirSep distributor, coordinating donation of AirSep Oxygen Systems to hospitals in Ghana in response to COVID-19 critical oxygen needs.
- Direct ReliefminorDirect Relief partnered with Build Health International to fund oxygen plant support on the island of Dominica, where the AirSep PSA Oxygen System is the only public oxygen supply system in the country.
- Build Health InternationalminorBuild Health International provides funding and support for oxygen system installations in developing countries, partnering with AirSep for equipment and Direct Relief for funding.
- Assist InternationalminorAssist International works with AirSep to deploy oxygen centers in Ethiopia, including the Nejo Oxygen Center which produces over 1800 cylinders of oxygen per month.
- Sunset Healthcare SolutionscoreSunset Healthcare Solutions is CAIRE's Canadian distributor, carrying FreeStyle Comfort portable oxygen concentrator, Eclipse 5 transportable oxygen concentrator, and accessories. Provides order fulfillment, logistics coordination, and direct shipment support across Canada.
- Careica HealthcoreCareica Health joined CAIRE's Authorized Service Network in August 2026 to support Canadian customers with in-warranty repairs for CAIRE oxygen therapy solutions including FreeStyle Comfort, Eclipse 5, and NewLife Intensity.
- MGC Diagnostics Holdings, Inc.coreCAIRE acquired MGC Diagnostics Holdings in January 2023 to expand its diagnostic and oxygen therapy portfolio for pulmonary diseases. MGC Diagnostics is a provider of non-invasive cardiorespiratory diagnostic systems located in Minnesota, serving patients with cardiorespiratory diseases affecting over 365 million people globally.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Caire competitors and assessment
Company assessmentDirect peers
- Invacare: Invacare is a long-standing home medical equipment manufacturer supplying oxygen concentrators, respiratory devices, and DME products to the same HME provider and homecare channel that CAIRE serves.
- Precision Medical: Precision Medical produces portable oxygen concentrators and respiratory therapy devices aimed at home and clinical use, competing head-to-head with CAIRE in lightweight POC and stationary oxygen categories.
- Chart Industries: Chart Industries designs and manufactures cryogenic and medical gas equipment including on-site oxygen generation and cylinder filling systems, directly comparable to CAIRE's AirSep PSA/VPSA oxygen and nitrogen generation portfolio.
- Inogen: Inogen is a publicly-traded medical device company specializing in portable oxygen concentrators for patients with chronic respiratory conditions, directly competing with CAIRE's FreeStyle Comfort and Eclipse 5 in the home-use portable oxygen market.
- Drive DeVilbiss Healthcare: Drive DeVilbiss Healthcare manufactures portable and stationary oxygen concentrators and a wide range of home respiratory equipment, directly competing with CAIRE's Companion 5 and NewLife Intensity stationary lines.
Broad incumbents
- Philips Respironics: Philips Respironics is a major incumbent in sleep and respiratory care offering stationary and portable oxygen concentrators, CPAP/BiPAP, and ventilators — overlapping with CAIRE's oxygen therapy portfolio as part of a much broader respiratory franchise.
- ResMed: ResMed is a global leader in sleep apnea and respiratory care devices with a strong home-channel footprint, competing with CAIRE in oxygen therapy while also serving overlapping HME providers and homecare channels.
- Linde Healthcare: Linde is a global industrial gas company supplying medical oxygen, on-site generation, and respiratory therapies to hospitals and homecare, comparable to CAIRE's medical and commercial oxygen generation offerings.
- Air Liquide Healthcare: Air Liquide is a global industrial and medical gas major supplying bulk oxygen, cylinder delivery, and on-site generation to hospitals — overlapping with CAIRE's AirSep hospital and on-site generation business but at much larger scale.
Emerging players
- ndd Medical Technologies: ndd Medical Technologies specializes in non-invasive pulmonary function and FeNO diagnostic devices, directly competing with CAIRE's MGC Diagnostics Fenom Flo and cardiorespiratory diagnostic portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Caire social profiles
Digital presenceCaire compliance and trust
Trust signalCompliance10 records
Caire financial estimates
Financial estimateRevenue estimate
Valuation estimate
Caire leadership team
Management profileNumber of profiles
Profiles5 records
Caire subsidiaries and ownership
Company hierarchySubsidiaries7 records
Caire funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Caire M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Caire
What does Caire do?
CAIRE manufactures and sells oxygen therapy products (portable and stationary oxygen concentrators, liquid oxygen systems) and cardiorespiratory diagnostic systems for medical and commercial use. The company also provides on-site PSA/VPSA oxygen and nitrogen generation systems for hospitals, industrial facilities, and military applications, operating under brands including AirSep, HELiOS, SeQual, and MGC Diagnostics.
Is Caire a public or private company?
Caire is a private company. It is classified as corporate owned and is currently operating.
When was Caire founded?
Caire was founded in 1970. It employs 501 to 1,000 people.
Where is Caire based?
Caire is headquartered in Ball Ground, United States, in the North America region.
How does Caire make money?
Four revenue lines are on record. Medical Oxygen Therapy Equipment Sales are the primary driver. The others are commercial/Industrial Oxygen Generation Systems, cardiorespiratory Diagnostic Systems and service and Support.
Who are Caire's main competitors?
Direct peers on record are Invacare, Precision Medical, Chart Industries, Inogen and Drive DeVilbiss Healthcare. Broad incumbents are Philips Respironics, ResMed, Linde Healthcare and Air Liquide Healthcare. ndd Medical Technologies is listed as an emerging player.
Does Caire have an API?
No public API is recorded for Caire.
What industry is Caire in?
Caire's product category is Medical Oxygen Therapy Equipment. Its primary akta.pro industry code is HLAHAGAD, Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC), with a secondary code of IMAHAKAG, Ventilation, Ducting & Air Distribution Equipment. Its NAICS code is 334510 and its SIC code is 3841.